Sarepta Therapeutics
SRPT
#1607
Rank
โ‚น894.47 B
Marketcap
โ‚น9,364
Share price
3.98%
Change (1 day)
35.31%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2024 (TTM): โ‚น5.18 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are โ‚น1.50 Billion. In 2023 the company made an earning of -โ‚น43.94 Billion, an increase over its 2022 earnings that were of -โ‚น58.29 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น5.18 B-111.81%
2023 -โ‚น43.94 Billion-24.62%
2022 -โ‚น58.29 Billion64.69%
2021 -โ‚น35.39 Billion-24.25%
2020 -โ‚น46.72 Billion-22.53%
2019 -โ‚น60.31 Billion96.87%
2018 -โ‚น30.63 Billion645.68%
2017 -โ‚น4.11 Billion-81.81%
2016 -โ‚น22.58 Billion21.47%
2015 -โ‚น18.59 Billion62.04%
2014 -โ‚น11.48 Billion21.26%
2013 -โ‚น9.46 Billion60.93%
2012 -โ‚น5.88 Billion93.69%
2011 -โ‚น3.04 Billion71.58%
2010 -โ‚น1.77 Billion35.06%
2009 -โ‚น1.31 Billion-11.62%
2008 -โ‚น1.49 Billion-47.02%
2007 -โ‚น2.8 Billion0.38%
2006 -โ‚น2.79 Billion88.3%
2005 -โ‚น1.48 Billion-30.06%
2004 -โ‚น2.12 Billion32.69%
2003 -โ‚น1.6 Billion-25.52%
2002 -โ‚น2.15 Billion64.52%
2001 -โ‚น1.31 Billion50.4%
2000 -โ‚น0.87 Billion26.44%
1999 -โ‚น0.69 Billion8%
1998 -โ‚น0.64 Billion102.7%
1997 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น129.91 B 2,371.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น23.12 Billion-539.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น21.33 Billion-505.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น12.38 Billion-335.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น15.79 Billion-400.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น41.74 Billion-894.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น65.94 Billion-1,354.49%๐Ÿ‡บ๐Ÿ‡ธ USA